Biohaven (BHVN) Common Equity (2021 - 2026)
Biohaven (BHVN) reported Common Equity of $129.5 million for Q1 2026, up 177297.26% on a YoY basis from N/an in Q1 2025, and up 148.69% sequentially from $52.1 million in Q4 2025.
Biohaven (BHVN) Common Equity (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Common Equity data on file, last reported at $129.5 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 177297.26% year-over-year to $129.5 million; the trailing twelve-month figure through Mar 2026 stood at $129.5 million (up 177297.26% YoY), and the FY2025 full-year result was $52.1 million, up 103.87% from the prior year.
- Common Equity advanced to $129.5 million in Q1 2026, from $52.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $911.0 million in Q1 2024 to a low of -$1.3 billion in Q4 2024.
- A 5-year average of -$7.9 million and a median of $25.0 million in 2022 frame the typical range for Common Equity.
- Peak annual rise in Common Equity reached 548673.49% in 2024, while the deepest fall reached 733562.66% in 2024.
- Tracing BHVN's Common Equity over 5 years: stood at $538.8 million in 2022, then slipped by 20.56% to $428.0 million in 2023, then sank by 414.44% to -$1.3 billion in 2024, then jumped by 103.87% to $52.1 million in 2025, then surged by 148.69% to $129.5 million in 2026.
- Business Quant data shows BHVN's Common Equity at $129.5 million in Q1 2026, $52.1 million in Q4 2025, and -$17.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 129.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.50 Mn |
| Dec 31, 2025 | 52.07 Mn |
| Sep 30, 2025 | -17.16 Mn |
| Jun 30, 2025 | 157.02 Mn |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | -1.16 Bn |
| Jun 30, 2024 | -75,000.00 |
| Mar 31, 2024 | 910.96 Mn |
| Dec 31, 2023 | 427.98 Mn |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 282,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 538.77 Mn |
| Sep 30, 2022 | 100.22 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Mar 31, 2022 | 46.10 Mn |
| Dec 31, 2021 | 34.69 Mn |
| Sep 30, 2021 | 321.51 Mn |